Dolby Laboratories Inc.
DLB | NYSE
$57.33
-$0.32 (-0.56%)
At close: Sep 21, 2026, 4:00 PM ET
$57.33
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:24 PM ET
Fiscal Year Period Ending | FY 2025 Sep 25, 2025 | FY 2024 Sep 26, 2024 | FY 2023 Sep 28, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 23, 2021 | FY 2020 Sep 24, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.35B | 1.27B | 1.3B | 1.25B | 1.28B | 1.16B |
Cost of Revenue | 160.13M | 140.5M | 152.57M | 141.36M | 130.03M | 146.5M |
Gross Profit | 1.19B | 1.13B | 1.15B | 1.11B | 1.15B | 1.02B |
Operating Income | 264.96M | 264.71M | 262.81M | 217.23M | 340.76M | 220.56M |
Interest Income | 15.38M | 34.08M | 28.09M | 6.57M | 3.49M | 12.73M |
Pretax Income | 303.49M | 312.48M | 250.05M | 215.28M | 354.51M | 239.72M |
Net Income | 255.02M | 261.83M | 200.66M | 184.09M | 310.23M | 231.36M |
Selling & General & Admin | 647.24M | 604.85M | 612.84M | 634.03M | 556.83M | 555.69M |
Research & Development | 261.79M | 263.66M | 271.52M | 261.17M | 253.64M | 239.05M |
Other Expenses | 15.01M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 924.04M | 868.52M | 884.36M | 895.21M | 810.47M | 794.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 360.71M | 334.46M | 354.36M | 358.72M | 332.67M | 335.93M |
Cost & Expenses | 1.08B | 1.01B | 1.04B | 1.04B | 940.5M | 941.23M |
Income Tax Expense | 46.99M | 48.16M | 48.41M | 31.38M | 36.69M | 8.1M |
Shares Outstanding (Basic) | 95.87M | 95.54M | 95.79M | 99.99M | 101.19M | 100.56M |
Shares Outstanding (Diluted) | 97.48M | 97.33M | 97.59M | 101.98M | 104.62M | 102.94M |
EPS (Basic) | 2.66 | 2.74 | 2 | 1.84 | 3.07 | 2.30 |
EPS (Diluted) | 2.62 | 2.69 | 1.96 | 1.81 | 2.97 | 2.25 |
EBITDA | 378.56M | 399.81M | 345.57M | 318.89M | 450.37M | 330.59M |
EBIT | 279.97M | 312.48M | 250.05M | 215.28M | 354.51M | 239.72M |
Depreciation & Amortization | 98.6M | 87.33M | 95.51M | 103.61M | 95.86M | 90.88M |
Add to Watchlist
Select watchlists to add or remove DLB